|
Adhesivo tisular biológico versus sutura estándar para el autotrasplante de conjuntiva en el tratamiento quirúrgico del pterigion [Biological tissue adhesive versus standard suture in conjuctival autograft for the surgical treatment of pterygium] |
Pichon Riviere, A., Augustovski, F., Garcia Marti, S., Glujovsky, D., Alcaraz, A., Lopez, A., Bardach, A. and Ciapponi, A. |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pichon Riviere, A., Augustovski, F., Garcia Marti, S., Glujovsky, D., Alcaraz, A., Lopez, A., Bardach, A. and Ciapponi, A.. Adhesivo tisular biológico versus sutura estándar para el autotrasplante de conjuntiva en el tratamiento quirúrgico del pterigion. [Biological tissue adhesive versus standard suture in conjuctival autograft for the surgical treatment of pterygium] Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rápida N°251. 2012 Authors' objectives To assess the available evidence on the efficacy, safety and issues related with coverage policies for the biological tissue adhesive in conjunctival autograft for the surgical treatment of pterygium. Authors' conclusions Good quality evidence was found on the benefits of the use of fibrin glue versus conventional suture in patients with pterygium who undergo conjunctival autograft. However, this benefit was limited to reducing surgical times in fewer minutes and to a lower level of discomfort in the post-surgical period. No differences were found as regards complications or recurrence rate. Most studies were conducted on patients with primary pterygium, although one study was conducted in patients with recurrent pterygium and showed similar results. No clinical practice guidelines on conjunctival autograft in patients operated for pterygium were found and no health sponsors covering this type of surgeries were found either; therefore this technology is not mentioned in their coverage policies. Based on the evidence found, the use of fibrin glue in conjunctival autograft would benefit patients being operated for pterygium. However, due to the difference in costs between both techniques, a cost-effectiveness analysis should be carried out in order to make a proper decision as regards covering this technology. Indexing Status Subject indexing assigned by CRD MeSH Autografts; Conjunctiva; Humans; Pterygium; Sutures; Tissue Adhesives Language Published Spanish Country of organisation Argentina English summary An English language summary is available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32014000314 Date abstract record published 31/01/2014 |
|
|
|